Insider Trading Alert - KEX, DORM And CNO Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, March 14, 2014, 135 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $39.62 to $83,032,124.16.

Highlighted Stocks Traded by Insiders:

Kirby (KEX) - FREE Research Report

Waterman William M. who is Director at Kirby sold 79,793 shares at $103.67 on March 14, 2014. Following this transaction, the Director owned 18,014 shares meaning that the stake was reduced by 81.58% with the 79,793-share transaction.

The shares most recently traded at $104.37, up $0.70, or 0.67% since the insider transaction. Historical insider transactions for Kirby go as follows:

  • 4-Week # shares sold: 58,624
  • 12-Week # shares sold: 118,849
  • 24-Week # shares sold: 126,322

The average volume for Kirby has been 422,200 shares per day over the past 30 days. Kirby has a market cap of $5.9 billion and is part of the services sector and transportation industry. Shares are up 5.07% year-to-date as of the close of trading on Friday.

Kirby Corporation, through its subsidiaries, provides marine transportation and diesel engine services primarily in the United States. Its Marine Transportation segment provides transportation services for the inland and coastal markets. The company has a P/E ratio of 23.5. Currently there are 6 analysts that rate Kirby a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KEX - FREE

TheStreet Quant Ratings rates Kirby as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, expanding profit margins and solid stock price performance. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Kirby Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Dorman Products (DORM) - FREE Research Report

Levin Edgar W who is Director at Dorman Products sold 2,000 shares at $58.84 on March 14, 2014. Following this transaction, the Director owned 70,052 shares meaning that the stake was reduced by 2.78% with the 2,000-share transaction.

The shares most recently traded at $59.86, up $1.02, or 1.7% since the insider transaction. Historical insider transactions for Dorman Products go as follows:

  • 4-Week # shares sold: 5,000
  • 12-Week # shares sold: 5,000
  • 24-Week # shares sold: 11,673

The average volume for Dorman Products has been 287,200 shares per day over the past 30 days. Dorman Products has a market cap of $2.2 billion and is part of the consumer goods sector and automotive industry. Shares are up 6.53% year-to-date as of the close of trading on Friday.

Dorman Products, Inc. supplies automotive replacement parts, automotive hardware, brake products, and household hardware to the automotive aftermarket and mass merchandise markets. The company has a P/E ratio of 26.6. Currently there are 4 analysts that rate Dorman Products a buy, 1 analyst rates it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on DORM - FREE

TheStreet Quant Ratings rates Dorman Products as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins, good cash flow from operations and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Dorman Products Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

CNO Financial Group (CNO) - FREE Research Report

Long Roger Keith who is Director at CNO Financial Group sold 81,000 shares at $18.72 on March 14, 2014. Following this transaction, the Director owned 461,100 shares meaning that the stake was reduced by 14.94% with the 81,000-share transaction.

The shares most recently traded at $18.82, up $0.10, or 0.53% since the insider transaction. Historical insider transactions for CNO Financial Group go as follows:

  • 4-Week # shares sold: 7,440
  • 12-Week # shares sold: 7,440
  • 24-Week # shares sold: 22,440

The average volume for CNO Financial Group has been 1.5 million shares per day over the past 30 days. CNO Financial Group has a market cap of $4.1 billion and is part of the financial sector and insurance industry. Shares are up 6.11% year-to-date as of the close of trading on Friday.

CNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance, and other insurance products for senior and middle-income markets in the United States. The stock currently has a dividend yield of 1.28%. The company has a P/E ratio of 9.1. Currently there is 1 analyst that rates CNO Financial Group a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CNO - FREE

TheStreet Quant Ratings rates CNO Financial Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, attractive valuation levels, notable return on equity and growth in earnings per share. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full CNO Financial Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null